Second in Series Virtual Roundtable with Illumina on Exploring the Role of Liquid Biopsy in Cancer Care

On March 13, 2025, Illumina in partnership with NTRKers Foundation, Inc., hosted a second in series virtual roundtable.

This session focused on the practical applications of liquid biopsy in cancer diagnosis and treatment. Interactive discussion included a review of what a liquid biopsy is, what its benefits are, and how it could impact the treatment journey of NTRK gene fusion cancer.

The informational slides presented during the virtual roundtable are available to view HERE.